Drug Shortage Report for RIVA-LATANOPROST
| Report ID | 161818 |
| Drug Identification Number | 02341085 |
| Brand name | RIVA-LATANOPROST |
| Common or Proper name | Riva-Latanoprost opht.50mcg / ml 2.5ml |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LATANOPROST |
| Strength(s) | 50MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 2.5 ml |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-06-10 |
| Actual start date | 2022-08-05 |
| Estimated end date | 2022-10-31 |
| Actual end date | 2022-11-18 |
| Shortage status | Resolved |
| Updated date | 2023-05-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-05-02 | French | Compare |
| v6 | 2023-05-02 | English | Compare |
| v5 | 2022-08-16 | French | Compare |
| v4 | 2022-08-16 | English | Compare |
| v3 | 2022-06-11 | English | Compare |
| v2 | 2022-06-03 | French | Compare |
| v1 | 2022-06-03 | English | Compare |
Showing 1 to 7 of 7